uniQure, Positive topline results from the pivotal phase I/II study of AMT-130 in Huntington’s disease (24 September 2025), PDF hosted by the Huntington’s Disease Society of America (sponsor’s own topline release)

https://hdsa.org/wp-content/uploads/2025/09/uniQure-Announces-Positive-Topline-Results-from-Pivotal-Phase-I_II-Study-of-AMT-130-in-Patients-with-Huntingtons-Disease.pdf

Authors. uniQure

Venue. PDF hosted by the Huntington’s Disease Society of America (sponsor’s own topline release)

How the Institute flags it

frontier 4 times

Cited on 4 pages

• Genetic Engineering
• Neurodegeneration Reversal
• Neurogenetics
• Neuroplasticity Engineering